» Articles » PMID: 33013414

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol

Overview
Journal Front Pharmacol
Date 2020 Oct 5
PMID 33013414
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

For nearly a century, has been stigmatized and criminalized across the globe, but in recent years, there has been a growing interest in due to the therapeutic potential of phytocannabinoids. With this emerging interest in , concerns have arisen about the possible contaminations of hemp with pesticides, heavy metals, microbial pathogens, and carcinogenic compounds during the cultivation, manufacturing, and packaging processes. This is of particular concern for those turning to for medicinal purposes, especially those with compromised immune systems. This review aims to provide types of contaminants and examples of contamination using case studies that elucidate the medical consequences consumers risk when using adulterated products. Thus, it is imperative to develop universal standards for cultivation and testing of products to protect those who consume .

Citing Articles

Same, yet different: towards understanding nutrient use in hemp- and drug-type Cannabis.

Wee Y B, Berkowitz O, Whelan J, Jost R J Exp Bot. 2024; 76(1):94-108.

PMID: 39180219 PMC: 11659179. DOI: 10.1093/jxb/erae362.


A three-years survey of microbial contaminants in industrial hemp inflorescences from two Italian cultivation sites.

Spampinato G, Candeliere F, Amaretti A, Paris R, Montanari M, Virzi N J Cannabis Res. 2024; 6(1):31.

PMID: 39020444 PMC: 11253326. DOI: 10.1186/s42238-024-00241-z.


Experiences and Perceptions of Medical Cannabis among People Living with Chronic Pain and Community Pharmacists: A Qualitative Study in Canada.

Dassieu L, Paul-Savoie E, Develay E, Villela Guilhon A, Guenette L, Perreault K Can J Pain. 2023; 7(1):2258537.

PMID: 38027232 PMC: 10653616. DOI: 10.1080/24740527.2023.2258537.


Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies.

Luz-Veiga M, Azevedo-Silva J, Fernandes J Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259306 PMC: 9958812. DOI: 10.3390/ph16020155.


Beyond cannabinoids: Application of NMR-based metabolomics for the assessment of L. crop health.

Fernandez S, Castro R, Lopez-Radcenco A, Rodriguez P, Carrera I, Garcia-Carnelli C Front Plant Sci. 2023; 14:1025932.

PMID: 37035042 PMC: 10075229. DOI: 10.3389/fpls.2023.1025932.


References
1.
Sreeram S, Lobo F, Acharya V, Saralaya V . A Fortuitous Turn of Evidence in an Elderly Female - A Case of Pulmonary Fusariosis. J Clin Diagn Res. 2017; 11(2):ED04-ED05. PMC: 5376773. DOI: 10.7860/JCDR/2017/24736.9191. View

2.
Jeong S, Yun H, Jeong Y, Jo M, Kang S, Kim J . Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells. Cancer Lett. 2019; 447:12-23. DOI: 10.1016/j.canlet.2019.01.011. View

3.
Zarn J, OBrien C . Current pesticide dietary risk assessment in light of comparable animal study NOAELs after chronic and short-termed exposure durations. Arch Toxicol. 2017; 92(1):157-167. PMC: 5773667. DOI: 10.1007/s00204-017-2052-4. View

4.
Sharafi G, He H, Nikfarjam M . Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer. J Pancreat Cancer. 2019; 5(1):1-7. PMC: 6352507. DOI: 10.1089/pancan.2018.0019. View

5.
Buha A, Wallace D, Matovic V, Schweitzer A, Oluic B, Micic D . Cadmium Exposure as a Putative Risk Factor for the Development of Pancreatic Cancer: Three Different Lines of Evidence. Biomed Res Int. 2018; 2017:1981837. PMC: 5733953. DOI: 10.1155/2017/1981837. View